Fernando Espinosa Abdalá (#2539)
- $ 2 B
- Pharmaceuticals
- Mexico
- M
- 76 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Fernando Espinosa Abdalá and his brother Leopoldo derive much of their fortune from the sale of their drug manufacturer Rimsa, which it sold to Tel Aviv-based Teva Pharmaceuticals for $2.3 billion. Fernando was the operational president of the company before the sale in 2016. Their father founded the business in 1970 as a pharmaceutical distributor before expanding into manufacturing. Following the sale, Teva sued Fernando and Leopoldo claiming fraud and a breach of contract. Most of the charges were dismissed; as for breach of contract, the parties eventually settled for less than $200 million.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Fernando Espinosa Abdalá’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Fernando Espinosa Abdalá’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.6B
(May 4, 2026)
© Iconic Billionaires